Sponsor:
University of Washington
Code:
NCT01508637
Conditions
Cardiovascular Effects
Eligibility Criteria
Sex: All
Age: 18 - 49
Healthy Volunteers: Accepted
Interventions
Diesel Exhaust
Filtered Air
Terazosin
placebo
Brief summary:
Conditions
Cardiovascular Effects
Study ID
NCT01508637
Start date
Jan, 2012
Status verified date
Jul, 2015
Completion date
Dec, 2015
Anticipated
Primary completion date
Dec, 2015
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 49
Healthy Volunteers: Accepted
Enrollment
24 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Prevention
Arms
experimental: Diesel Exhaust + Terazosin
experimental: Diesel Exhaust + placebo
sham comparator: Filtered Air + terazosin
sham comparator: Filtered air + placebo
Interventions
Diesel Exhaust
Filtered Air
Terazosin
placebo
Primary outcome measure
Central contacts
Locations
University of Washington Medical Center
Recruiting
Seattle, Washington, United States, 98195
Sponsor
University of Washington
Last update posted
Aug 3, 2015
Last verified
Jul, 2015
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Washington on 2015-08-03.